María del Carmen García García

Dr. María del Carmen García García


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2000 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
Miguel LopezMiguel Lopez
Miguel Lopez
LSLuisa Seoane
Luisa Seoane
MGMaría del Carmen García García
María del Carmen García García
FLFrancisca Lago
Francisca Lago
FCFelipe F Casanueva
Felipe F Casanueva
CDCarlos Diéguez
Carlos Diéguez

1 May 2006 in Diabetes
Verified
Journal Article
Closed access
PDF file
MGMaría del Carmen García García
María del Carmen García García
IAIngrid Wernstedt Asterholm
Ingrid Wernstedt Asterholm
ABAnna Berndtsson
Anna Berndtsson
MEMaria Enge
Maria Enge
MBMichal Bell
Michal Bell
JJJohn-Olov Jansson
John-Olov Jansson
Interleukin-1 (IL-1) is a major mediator of inflammation that exerts its biological activities through the IL-1 type I receptor (IL-1RI). The body weights of IL-1RI−/− mice of both sexes started to deviate from those of wild-type mice at 5–6 months of age and were 20% higher at 9 months of age. Visceral and subcutaneous fat mass, measured by dual-energy X-ray absorptiometry and magnetic resonance imaging, was markedly (1.5- to 2.5-fold) increased. Lean body mass and crown-rump length were also slightly (11 and 5%, respectively) increased, as was serum IGF-I. Obese IL-1RI−/− mice were insulin resistant, as evidenced by hyperinsulinemia, decreased glucose tolerance, and insulin sensitivity. To elucidate the mechanisms for the development of obesity, young preobese IL-1RI−/− mice were investigated. They showed decreased suppression of body weight and food intake in response to systemic leptin treatment. The decreased leptin responsiveness was even more pronounced in older obese animals. Moreover, spontaneous locomotor activity and fat utilization, as measured by respiratory quotient, were decreased in preobese IL-1RI−/− mice. In conclusion, lack of IL-1RI–mediated biological activity causes mature-onset obesity. This obese phenotype is preceded by decreased leptin sensitivity, fat utilization, and locomotor activity.

1 March 2000 in Biology of Reproduction
Verified
Journal Article
Closed access
MGMaría del Carmen García García
María del Carmen García García
FCFelipe F. Casanueva
Felipe F. Casanueva
CDCarlos Diéguez
Carlos Diéguez
RSRosa María Señarís
Rosa María Señarís
Serum leptin levels were significantly increased during rat gestation. Our data showed that leptin mRNA levels in both the adipose tissue and placenta were higher as pregnancy progressed, suggesting a role for both tissues in the hyperproduction of leptin. This paradoxical increase in leptin concentration during gestation suggests that a physiological state of leptin resistance may exist at the hypothalamic level that may explain the hyperphagia observed in pregnant rats. In order to study this issue further, levels of the mRNA encoding the different leptin receptor isoforms were determined in the hypothalamus of pregnant and nonpregnant rats. We found a specific reduction of the mRNA levels encoding the leptin receptor isoform Ob-Rb in the hypothalamus of pregnant rats compared to nonpregnant animals, suggesting that during pregnancy the hypothalamus shows a physiological resistance to the high levels of leptin due, at least in part, to a decrease in the expression of the long, biologically active form of the leptin receptor (Ob-Rb). During lactation, serum leptin levels returned to values observed in nonpregnant rats. In the hypothalami of these animals, Ob-Rb mRNA content was similar to that observed in nonpregnant rats, but we found an increased expression of some of the short forms of the leptin receptor (Ob-Re and Ob-Rf). This could contribute to induction of the hyperphagia present during lactation. These data provide new insights into the adaptive mechanisms that take place during pregnancy and lactation in order to meet increased metabolic requirements.

23 December 2004 in Diabetologia
Verified
Journal Article
Closed access
PDF file
LSL. M. Seoane
L. M. Seoane
STSulay Tovar
Sulay Tovar
RNRuben Nogueiras
Ruben Nogueiras
Miguel LopezMiguel Lopez
Miguel Lopez
MGMaría del Carmen García García
María del Carmen García García
RSR. M. Señarís
R. M. Señarís

1 August 2003 in The FASEB Journal
Verified
Journal Article
Closed access
MGMaría del Carmen García García
María del Carmen García García
Miguel LopezMiguel Lopez
Miguel Lopez
Oreste GualilloOreste Gualillo
Oreste Gualillo
LSL. M. Seoane
L. M. Seoane
CDC. Diéguez
C. Diéguez
RSRosa Maria Señarís
Rosa Maria Señarís

1 January 2002 in Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
Miguel LopezMiguel Lopez
Miguel Lopez
LSLuisa María Seoane
Luisa María Seoane
MGMaría del Carmen García García
María del Carmen García García
CDCarlos Diéguez
Carlos Diéguez
RSRosa Señarís
Rosa Señarís
We examined the effects of orexin A on the mRNA levels of neuropeptide Y, agouti-related peptide, melanin-concentrating hormone, prepro-orexin and orexin receptors in the rat hypothalamus. Adult male rats were treated centrally (i.c.v.) with a single dose of orexin A (3 nmol). After 2, 6 and 12 h, neuropeptide Y, agouti-related peptide, melanin-concentrating hormone, and prepro-orexin mRNA levels were measured by semiquantitative RT-PCR and in situ hybridization; orexin receptors mRNA content was quantified by semiquantitative RT-PCR. We found that orexin A increased neuropeptide Y expression in the arcuate nucleus of the rat hypothalamus. This stimulatory effect was transient, being observed 2 h after the treatment, and disappearing after longer periods (6 and 12 h). In contrast, no change was demonstrated in hypothalamic agouti-related peptide, melanin-concentrating hormone, prepro-orexin or orexin receptors mRNA levels at any time evaluated. Our results suggest that neuropeptide Y synthesized in the arcuate nucleus of the hypothalamus, but not agouti-related peptide and melanin-concentrating hormone pathways, is likely involved in orexin-induced feeding behavior, and raise the possibility that this functional linkage may also be involved in other actions mediated by orexins such as locomotor activity and sympathetic function.